The medical-device maker reports earnings on Tuesday.

I am honored to be with you as we gather to celebrate your graduation. This school has a distinguished roster of graduates... Earl Bakken, the founder of Medtronic, was an Electrical Engineering grad; and Bob Gore of Gortex and your current pres

By Peter Geschek:At this point an artificial pancreas is only a concept rather than a clinical reality.A small implantable device, an artificial pancreas would continuously monitor blood-sugar levels and release insulin as needed in patients with Typ

Data presented today at Heart Rhythm2013, the Heart Rhythm Society's 34^th Annual Scientific Sessions, show thatMedtronic (NYSE: MDT) Lead Integrity Alert (LIA) software detectedpace/sense lead issues in non-Medtronic leads at a greater rate than sta

By Peter Geschek:Renal denervation therapy is a new, minimally invasive procedure that will help people with hopelessly high blood pressure that just refuses to budge to medication. The procedure is promising to become a major income source for devic

In keeping with its commitment to keep physiciansinformed about product performance and safety, Medtronic, Inc.

Medtronic, Inc.

April 23 (Reuters) - Edwards Lifesciences Corp said on Tuesday first-quarter net earnings more than doubled, boosted by a large gain from patent litigation with Medtronic Inc , but the heart valve maker lowered its 2013 outlook due to sluggish sales

ARCA biopharma (Nasdaq: ABIO), a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that it has entered into an agreement with Medtronic, Inc.

The current issue of JACC: CardiovascularInterventions, a peer-reviewed journal published by the American College ofCardiology, includes an article that describes how the Resolute Integritydrug-eluting stent from Medtronic, Inc. (NYSE: MDT) became th

Medtronic, Inc. (NYSE: MDT) today announced thefirst patient enrollments in the SubQStim II pivotal clinical trial to pursueU.S. Food and Drug Administration (FDA) approval of peripheral nervestimulation (PNS), also known as subcutaneous nerve stimul

Presented to endovascular specialists at the35^th Charing Cross International Symposium in London, a new analysis ofclinical data on the Endurant AAA Stent Graft System from Medtronic, Inc.(NYSE: MDT) demonstrates the implanted medical device's consi

Urologix, Inc. (Nasdaq: ULGX),the leading provider of in-office BPH therapy, today announced that it hasreached an important milestone in its licensing agreement with Medtronic forthe Prostiva RF Therapy System.

ByRobert Honeywill:The Two Technologies In summaryBoth the pacemaking and counter-pulsation technologies support the heart function.The pacemaking technology progressed quickly to permanent use outside of a hospital environment due to the inventivene

ByRobert Honeywill:The Two Technologies In summaryBoth the pacemaking and counter-pulsation technologies support the heart function.The pacemaking technology progressed quickly to permanent use outside of a hospital environment due to the inventivene

Complementing its market-leading portfolio ofstent grafts for the endovascular repair of aortic aneurysms and relatedconditions, Medtronic, Inc.

Medtronic, Inc. (NYSE: MDT) today announced U.S.Food and Drug Administration (FDA) 510(k) clearance and the first U.S.clinical uses of its new Affinity Fusion^® oxygenation system.

Looking at the universe of stocks we cover at Dividend Channel, on 4/3/13, Medtronic, Inc. (NYSE: MDT) will trade ex-dividend, for its quarterly dividend of $0.26, payable on 4/26/13. As a percentage of MDT's recent stock price of $46.94, this d

By Dividends4Life: Linked here is a detailed quantitative analysis of Medtronic Inc. (MDT). Below are some highlights: Company Description:Medtronic Inc.is a global medical device manufacturer with leadershippositions in the pacemaker, defibrillator

By Amod Saul:Medtronic (NYSE:MDT) executives are well known for their keen eye for spotting emerging technology trends and capitalizing on them early on. Their acquisition of Ardian, in the renal denervation space, is a case in point. However, someti

Medtronic has experienced weakness in some of its core markets recently, so is its dividend still rock-solid?

Medtronic, Inc. (MDT)Barclays Global Healthcare Conference CallMarch 13, 2013, 03:15 pm ETExecutivesGary Ellis - SVP & CFOAnalystsPresentationUnidentified AnalystThanks for joining us for another afternoon session. Pleased to have Medtronic with us h

Medtronic, Inc. (NYSE: MDT), announced todaythat the company has submitted an Investigational Device Exemption (IDE) tothe U.S.

Medtronic Inc. (MDT)Cowen Health Care Conference CallMarch 6, 2013 10:00 am ETExecutivesChristopher J. O’Connell – Executive Vice President and Group President, Restorative Therapies GroupAnalystsJosh T. Jennings – Cowen & Co. LLCPresentationJo

Medtronic, Inc. (NYSE: MDT) today announced theU.S.

Medtronic, Inc. (NYSE: MDT) today announced ithas received CE (Conformité Européenne) Mark and will begin the Europeanlaunch of the Attain Performa^® portfolio of quadripolar leads.

Of relevance to the clinical practice ofinterventional cardiology, Medtronic, Inc.

By EP Vantage:Medtronic parked its tanks squarely on Edwards Lifesciences' lawn yesterday by CE marking its Engager transcatheter aortic valve. Unlike CoreValve, the other transcatheter valve Medtronic sells in Europe, the device is delivered transap

Medtronic, Inc.

In a meta-analysis of seven studies published inthe January issue of Laryngoscope, Ji Ho Choi, M.D., Ph.

ByUlfberht Capital:Executive Summary:We believe that Medtronic (MDT) is a high quality company with a Business Quality Score of 7 based on a scale of 1 to 10 (10 is best). Also, shares of Medtronic appear to be undervalued based on a discounted cash

Feb 25 (Reuters) - Feb 25 (Reuters) - Medtronic Inc : * FDA approves longer lengths of medtronic's resolute integritystent * FDA approved 34mm,38mm lengths of resolute integritydrug-eluting stent in

Expanding the applicability of its marqueeproduct for the interventional treatment of coronary artery disease in theUnited States, Medtronic, Inc. (NYSE: MDT) announced today that the U.S.

By greg group: Typically, when you think of medical device companies focusing on the eastern part of the globe, you think of the relocation of manufacturing to lower cost through cheaper labor and supplies. Due to a growing middle class, China and In

By Stephen Simpson:The biggest obstacle for med-tech giant Medtronic (MDT) today is not its competition nor the still-sleepy markets for medical procedures. Instead, the biggest problem Medtronic has is a market/investor base that seems unwilling to

In a report published Wednesday, BMO Capital Markets reiterated its Outperform rating on Medtronic (NYSE: MDT), and raised its price target from $50.00 to $52.00.BMO Capital Markets noted, “Medtronic's FY3Q13 revenue was in line, EPS beat, and mana

The company credited a larger market share, but an analyst said a tax credit buoyed earnings.

By Vince Martin:It was fun while it lasted. Shares of Medtronic (MDT) had an excellent start to 2013, rising nearly 15% year-to-date before Tuesday, a strong bull run for the low-beta health-care supplier. That strength, however, may have built in hi

Medtronic's quarterly earnings rose 5.7% as the medical-devices company reported stronger revenue despite soft markets for some spine and heart products.

Here's your Cheat Sheet to earnings...

Medtronic, Inc. (MDT)F3Q 2013 Earnings Conference CallFebruary 19, 2013 08:00 ETExecutivesJeff Warren - Vice President, Investor RelationsOmar Ishrak - Chairman and Chief Executive OfficerGary Ellis - Chief Financial OfficerChris O'Connell - Presiden

NEW YORK, Feb 19 (Reuters) - Medtronic Inc : * Shares down 0.9 percent in premarket trading

Medtronic (NYSE: MDT) reported a 5.7% rise in its fiscal third-quarter earnings.Medtronic's quarterly profit surged to $988 million, or $0.97 per share, from $935 million, or $0.88 per share, in the year-ago period. Excluding one-time items, its adju

The maker of implantable heart devices and insulin pumps reported higher quarterly earnings as sales rose slightly.

Feb 19 (Reuters) - Medtronic Inc on Tuesday reportedhigher quarterly earnings as sales rose slightly.

Feb 19 (Reuters) - Medtronic Inc on Tuesday reportedhigher quarterly earnings as sales rose slightly.

Among the companies whose shares are expected to see active trade in Tuesday’s session are Dell, Herbalife, and Medtronic. The stock market will close on Monday for Presidents Day holiday.